We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Capecitabine in Women With Operable Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00148720
Recruitment Status : Terminated (Slow accrual)
First Posted : September 8, 2005
Last Update Posted : November 11, 2015
Hoffmann-La Roche
Beth Israel Deaconess Medical Center
Brigham and Women's Hospital
Information provided by (Responsible Party):
Ian E. Krop, MD, PhD, Dana-Farber Cancer Institute